Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression (Q39099604)

9 September 2017

Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression (English)

1 reference

9 September 2017

1 reference

Xiangyong Li

1

1 reference

9 September 2017

Yun Feng

2

1 reference

9 September 2017

Jinhua Liu

3

1 reference

9 September 2017

Xiaowei Feng

4

1 reference

9 September 2017

Keyuan Zhou

5

1 reference

9 September 2017

Xudong Tang

6

1 reference

9 September 2017

language of work or name

1 reference

31 August 2013

1 reference

Journal of Nutrigenetics and Nutrigenomics

9 September 2017

1 reference

9 September 2017

6

1 reference

9 September 2017

3

1 reference

9 September 2017

169-178

1 reference

Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells

9 September 2017

1 reference

Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives

21 January 2018

1 reference

Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications

21 January 2018

1 reference

Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction

21 January 2018

1 reference

Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate

21 January 2018

1 reference

Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy

21 January 2018

1 reference

Angiogenesis inhibited by drinking tea.

21 January 2018

1 reference

Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate

21 January 2018

1 reference

Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis

21 January 2018

1 reference

Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer

21 January 2018

1 reference

Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells

21 January 2018

1 reference

EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G.

21 January 2018

1 reference

(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells

21 January 2018

1 reference

Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway

21 January 2018

1 reference

Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells

21 January 2018

1 reference

(-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis

21 January 2018

1 reference

Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG.

21 January 2018

1 reference

Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α.

21 January 2018

1 reference

Targeting tumor angiogenesis with histone deacetylase inhibitors

21 January 2018

1 reference

Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery

21 January 2018

1 reference

Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer

21 January 2018

1 reference

Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis

21 January 2018

1 reference

Hypoxia-inducible factors: crosstalk between inflammation and metabolism

21 January 2018

1 reference

Influence of hypoxia-inducible factor 1α on dendritic cell differentiation and migration.

21 January 2018

1 reference

GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α

21 January 2018

1 reference

Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

21 January 2018

1 reference

Overexpression of human papillomavirus (HPV) type 16 oncoproteins promotes angiogenesis via enhancing HIF-1α and VEGF expression in non-small cell lung cancer cells

21 January 2018

1 reference

Loss of fibroblast HIF-1α accelerates tumorigenesis.

21 January 2018

1 reference

Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB

21 January 2018

1 reference

Effects of point mutations in pVHL on the binding of HIF-1α.

21 January 2018

1 reference

Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway

21 January 2018

1 reference

Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle

21 January 2018

1 reference

Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells

21 January 2018

1 reference

Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells

21 January 2018

1 reference

Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells

21 January 2018

1 reference

Regulation of hypoxia-inducible factor-1α (HIF-1α) expression by interleukin-1β (IL-1 β), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes

21 January 2018

1 reference

Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.

21 January 2018

1 reference

Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.

21 January 2018

1 reference

Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000354402

1 reference

9 September 2017

1 reference